LexDanaLexDanabeta
Inventor

Robert Tam

Inventor
Irvine, CA, US

Overview

21→
Patents
1998–2010
Patent span
Human necessities
Primary field (CPC A)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Hprimary
C07HSugars31%
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds6%
Y02ATechnologies for adaptation to climate change6%
C12NMicroorganisms or enzymes4%
PatentTitleYear
7,652,047'Phenylamino isothiazole carboxamidines as MEK inhibitors'20107,638,496'Nucleoside analogs with carboxamidine modified monocyclic base'20097,465,742'Heterocyclic compounds having anti-HBV activity'20087,429,667'Phenylamino isothiazole carboxamidines as MEK inhibitors'20087,056,895'Tirazole nucleoside analogs and methods for using same'20066,994,959'G-rich oligo aptamers and methods of modulating an immune response'20066,831,069'Pyrrolo2,3-dpyrimidine nucleoside analogs'20046,642,206'Monocyclic L-nucleosides, analogs and uses thereof'20036,573,248'Monocyclic L-nucleosides, analogs and uses thereof'20036,552,183'Moncyclic L-nucleosides analogs'20036,518,253'Treatment of viral infections using the L-isomer of ribavirin'20036,509,320'Purine L-nucleosides, analogs and uses thereof'20036,479,463'Purine L-nucleosides, analogs and uses thereof'20026,455,508'Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides'20026,455,690'L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosine'20026,423,695'Cytokine related treatments of disease'20026,150,337'Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes'20006,130,326'Monocyclic L-Nucleosides, analogs and uses thereof'20006,063,772'Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes'20005,932,556'Methods and compositions for regulation of CD28 expression'19995,767,097'Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1998–2003Patents assigned to ICN PHARMACEUTICALS (9)· patent assignee history
1998–2003Based in Costa Mesa, CA, US· patent location history
2000–2010Based in Irvine, CA, US· patent location history
2002–2004Patents assigned to RIBAPHARM INC (2)· patent assignee history
2008–2010Patents assigned to ARDEA BIOSCIENCES INC (2)· patent assignee history
2008Patents assigned to CHEN HUANMING (1)· patent assignee history
2008Patents assigned to RANEY ANNEKE K (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ICN PHARMACEUTICALS91998–2003
ARDEA BIOSCIENCES INC22008–2010
RIBAPHARM INC22002–2004
CHEN HUANMING12008
RANEY ANNEKE K12008
Locations
LocationPatentsSpan
Irvine, California, US142000–2010
Costa Mesa, California, US71998–2003